Dialysis News and Research

Latest Dialysis News and Research

ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients

Most Canadians living with CKD have likely never spoken with their physicians about calcium and the serious health risks associated with its overuse. This is why Improving Patient Advocacy in Chronic Kidney Disease (ImPACKD), a group of CKD patients and caregivers committed to raising awareness about the risks of calcium overuse, is starting the conversation about the importance of knowing the limits and keeping them in check.

20 Oct 2009

URL Pharma's Colcrys approved by FDA for prevention of gout flares

URL Pharma, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Colcrys(TM) (colchicine, USP) for the prophylaxis (prevention) of gout flares. Colcrys was first approved by the FDA on July 30, 2009 for the treatment of acute gout flares when taken at the first sign of a flare.

19 Oct 2009

CytoSorb human clinical trials nearing completion

TapeBeat.com, the news and research portal for the serious bio-tech investor in conjunction with the Farseers Group is proud to profile one of the most exciting up and coming biotech companies, MedaSorb Technologies (MSBT.OB), which is perfectly poised to realize exponential growth.

19 Oct 2009

Studies find frail seniors often get poor, futile care

Two studies published in the New England Journal of Medicine find that some medical care, especially at the end of life, may be a poor choice for feeble seniors. They also show the importance of palliative care over aggressive treatment for certain patients.

19 Oct 2009

FDA grants marketing approval for Elitek

Sanofi-aventis U.S. announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Elitek (rasburicase) to be used for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevations of plasma uric acid.

19 Oct 2009

Coronary angiography does not affect kidney functioning in CKD patients, reveals study

A screening test that measures whether a patient's heart is healthy enough for a kidney transplant is not as dangerous as once thought, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

19 Oct 2009

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Baxter International Inc. today reported solid financial results for the third quarter of 2009, and provided its fourth quarter and updated full-year 2009 financial outlook.

From Baxter International Inc. 15 Oct 2009

Nephrologists should weigh the benefits of dialysis over more conservative therapies for frail elders

Kidney specialists should weigh the potential quality of life for frail elders with end-stage renal disease (ESRD) in opting for dialysis over more conservative therapies, a nephrologist and a palliative care specialist suggest in an editorial in the New England Journal of Medicine.

15 Oct 2009

Important issues facing nephrologists to be presented by Satellite Healthcare

Satellite Healthcare, one of the nation's first and leading providers of kidney dialysis services and a major sponsor of nephrology research, today announced that its chief researchers will present at The American Society of Nephrology (ASN) Renal Week 2009.

14 Oct 2009

New Ultra Sensitive facemasks to protect against seasonal and swine flu

BIOSAFE, Inc., a company that manufactures and sells a novel antimicrobial polymer, has announced that they are launching in specific markets outside the United States through a unique facemask treated with BIOSAFE(®). Crosstex' new BIOSAFE-treated Ultra Sensitive facemasks begin to reduce microorganisms such as MRSA, VRE, and Staph immediately upon contact, and have further proven to be effective against Influenza A strains such as seasonal flu and the novel H1N1 virus.

14 Oct 2009

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

Kidney Care Partners - an alliance of patient advocates, dialysis professionals, care providers and manufacturers working together to improve quality of care for individuals with kidney disease and kidney failure - today applauded the Congressional Black Caucus (CBC) for supporting reforms that will improve patient access and choice in receiving quality kidney care.

13 Oct 2009

VitalProteinRx nutritional supplement for chronic kidney disease affected patients

VitalRemedyMD, a physician-established company, offers scientifically formulated integrative nutritional supplements designed to improve the quality of traditional healthcare. "We are proud that VitalProteinRx is now an integral part of Fresenius' armamentarium in helping patients with chronic kidney disease," stated Dr. Seth Baum, Founder of VitalRemedyMD.

13 Oct 2009

MEDLINE multi-purpose electronic database helps doctors care for their patients

Research funded by The Kidney Foundation of Canada and led by kidney specialists at Lawson Health Research Institute and The University of Western Ontario will make it possible for doctors to quickly and effectively access information relevant for patient care.

12 Oct 2009

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

CANTEL MEDICAL CORP. reported a 65% increase in net income to $4,279,000, or $0.26 per diluted share, on a 4% increase in sales to a record $66,793,000 for the fourth quarter ended July 31, 2009. This compares with net income of $2,596,000, or $0.16 per diluted share, on sales of $64,281,000 for the fourth quarter ended July 31, 2008.

9 Oct 2009

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

MedaSorb Technologies Corporation and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant attached to the Series B financing completed in August 2008. Dr. Phillip Chan, Chief Executive Officer, stated, "We are pleased to have the continued support of our existing investors.

9 Oct 2009

AST assembles at Capitol Hill to support health care reform for kidney transplant recipients

As Congress wraps up work on health care reform, members of the American Society of Transplantation's (AST) Public Policy Committee arrived on Capitol Hill today to discuss the importance of supporting a health care provision that would ensure kidney transplant recipients continue to receive.

9 Oct 2009

AST urges Senate Finance Committee to adopt a health care provision for transplant drug extension

As the Senate Finance Committee prepares to vote on the amended health care reform package, members of the American Society of Transplantation (AST) arrived on Capitol Hill armed with a letter encouraging the Senate to adopt a health care provision that will extend Medicare's coverage of post-transplant drugs, which are critical to maintaining the health of the transplant patient. Immunosuppressive drugs are currently covered for a period of 36 months.

9 Oct 2009

Lifeline Vascular Access receives re-accreditation from Joint Commission

Lifeline Vascular AccessSM, the nation’s leading provider of vascular access management services, announced today that it has been re-accredited by the Joint Commission - demonstrating compliance with the Joint Commission’s national standards for health care quality and safety.

8 Oct 2009

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Sumatriptan Succinate Injection, USP, in two dosage strengths.

8 Oct 2009

Shire publishes efficacy study results of FOSRENOL and Renagel

Shire plc, the global specialty biopharmaceutical company, today announces the publication in Clinical Nephrology of findings from a head-to-head clinical study comparing the efficacy of two non-calcium based phosphate binders, FOSRENOL(R) (lanthanum carbonate) and sevelamer hydrochloride (Genzyme's Renagel(R)) in chronic kidney disease (CKD) patients on haemodialysis.

7 Oct 2009

Dialysis News and Research

Latest Dialysis News and Research

ImPACKD calls for raising awareness about the risks of calcium overuse in CKD patients

URL Pharma's Colcrys approved by FDA for prevention of gout flares

CytoSorb human clinical trials nearing completion

Studies find frail seniors often get poor, futile care

FDA grants marketing approval for Elitek

Coronary angiography does not affect kidney functioning in CKD patients, reveals study

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Nephrologists should weigh the benefits of dialysis over more conservative therapies for frail elders

Important issues facing nephrologists to be presented by Satellite Healthcare

New Ultra Sensitive facemasks to protect against seasonal and swine flu

Kidney Care Partners commends CBC for supporting reforms to improve access to quality kidney care

VitalProteinRx nutritional supplement for chronic kidney disease affected patients

MEDLINE multi-purpose electronic database helps doctors care for their patients

Cantel Medical announces fiscal 2009 fourth-quarter and full-year financial results

MedaSorb Technologies raises $1.3 million to help finance ongoing European Sepsis Trial

AST assembles at Capitol Hill to support health care reform for kidney transplant recipients

AST urges Senate Finance Committee to adopt a health care provision for transplant drug extension

Lifeline Vascular Access receives re-accreditation from Joint Commission

APP Pharmaceuticals receives FDA approval to market Sumatriptan Succinate Injection

Shire publishes efficacy study results of FOSRENOL and Renagel

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in